Ming-Chu Hsu
Director/Miembro de la Junta en TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED .
Cargos activos de Ming-Chu Hsu
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Director/Miembro de la Junta | 02/01/2019 | - |
| Director Ejecutivo | 01/04/2001 | - | |
| Presidente | 01/04/2001 | 02/01/2019 | |
| Contacto de Relaciones con Inversores | 01/04/2001 | - | |
| Public Communications Contact | 01/04/2001 | - | |
| Presidente | - | - | |
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Director Ejecutivo | 01/01/2001 | - |
| Presidente | 01/05/2001 | - | |
| Fundador | 16/11/2009 | - | |
| Presidente | 01/05/2001 | - |
Historial de carrera de Ming-Chu Hsu
Antiguos cargos conocidos de Ming-Chu Hsu.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | Corporate Officer/Principal | - | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Director Técnico/Científico/I+D | - | - |
| National Health Research Institutes | Corporate Officer/Principal | - | - |
| The Rockefeller University | Corporate Officer/Principal | - | - |
Formación de Ming-Chu Hsu.
| University of Illinois | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Taiwán | 4 |
Operativa
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
| Chairman | 2 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Health Technology |
| Empresas privadas | 3 |
|---|---|
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
| National Health Research Institutes |
- Bolsa de valores
- Insiders
- Ming-Chu Hsu
- Experiencia
